Literature DB >> 28573701

Molecular and clinical delineation of 2p15p16.1 microdeletion syndrome.

Jonathan Lévy1,2, Aurélie Coussement3, Céline Dupont1, Fabien Guimiot2,4, Clarisse Baumann1, Géraldine Viot3, Sandrine Passemard1,2, Yline Capri1, Séverine Drunat1, Alain Verloes1, Eva Pipiras1,2,5, Brigitte Benzacken1,2,5, Jean-Michel Dupont3, Anne-Claude Tabet1,6.   

Abstract

Interstitial 2p15p16.1 microdeletion is a rare chromosomal syndrome previously reported in 33 patients. It is characterized by intellectual disability, developmental delay, autism spectrum disorders, microcephaly, short stature, dysmorphic features, and multiple congenital organ defects. It is defined as a contiguous gene syndrome and two critical regions have been proposed at 2p15 and 2p16.1 loci. Nevertheless, patients with deletion of both critical regions shared similar features of the phenotype and the correlation genotype-phenotype is still unclear. We review all published cases and describe three additional patients, to define the phenotype-genotype correlation more precisely. We reported on two patients including the first prenatal case described so far, carrying a 2p15 deletion affecting two genes: XPO1 and part of USP34. Both patients shared similar features including facial dysmorphism and cerebral abnormalities. We considered the genes involved in the deleted segment to further understand the abnormal phenotype. The third case we described here was a 4-year-old boy with a heterozygous de novo 427 kb deletion encompassing BCL11A and PAPOLG at 2p16.1. He displayed speech delay, autistic traits, and motor stereotypies associated with brain structure abnormalities. We discuss the contribution of the genes included in the deletion to the abnormal phenotype. Our three new patients compared to previous cases, highlighted that despite two critical regions, both distal deletion at 2p16.1 and proximal deletion at 2p15 are associated with phenotypes that are very close to each other. Finally, we also discuss the genetic counseling of this microdeletion syndrome particularly in the course of prenatal diagnosis.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  2p15p16.1 microdeletion; BCL11A; CNV; XPO1; corpus callosum agenesis

Mesh:

Substances:

Year:  2017        PMID: 28573701     DOI: 10.1002/ajmg.a.38302

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  7 in total

Review 1.  Pathogenesis of Choledochal Cyst: Insights from Genomics and Transcriptomics.

Authors:  Yongqin Ye; Vincent Chi Hang Lui; Paul Kwong Hang Tam
Journal:  Genes (Basel)       Date:  2022-06-08       Impact factor: 4.141

2.  Neurodevelopmental disease genes implicated by de novo mutation and copy number variation morbidity.

Authors:  Bradley P Coe; Holly A F Stessman; Arvis Sulovari; Madeleine R Geisheker; Trygve E Bakken; Allison M Lake; Joseph D Dougherty; Ed S Lein; Fereydoun Hormozdiari; Raphael A Bernier; Evan E Eichler
Journal:  Nat Genet       Date:  2018-12-17       Impact factor: 38.330

Review 3.  MOLECULAR MEDICINE: Found in Translation.

Authors:  Stuart H Orkin
Journal:  Med (N Y)       Date:  2021-01-12

4.  A Japanese boy with double diagnoses of 2p15p16.1 microdeletion syndrome and RP2-associated retinal disorder.

Authors:  Kazuki Yamazawa; Kenji Shimizu; Hirofumi Ohashi; Hidenori Haruna; Satomi Inoue; Haruka Murakami; Tatsuo Matsunaga; Takeshi Iwata; Kazushige Tsunoda; Kaoru Fujinami
Journal:  Hum Genome Var       Date:  2021-12-17

5.  Genome-wide association study of musical beat synchronization demonstrates high polygenicity.

Authors:  Maria Niarchou; Daniel E Gustavson; J Fah Sathirapongsasuti; Manuel Anglada-Tort; Else Eising; Eamonn Bell; Evonne McArthur; Peter Straub; J Devin McAuley; John A Capra; Fredrik Ullén; Nicole Creanza; Miriam A Mosing; David A Hinds; Lea K Davis; Nori Jacoby; Reyna L Gordon
Journal:  Nat Hum Behav       Date:  2022-06-16

Review 6.  The ASD Living Biology: from cell proliferation to clinical phenotype.

Authors:  Eric Courchesne; Tiziano Pramparo; Vahid H Gazestani; Michael V Lombardo; Karen Pierce; Nathan E Lewis
Journal:  Mol Psychiatry       Date:  2018-06-22       Impact factor: 15.992

7.  Widespread transcriptional disruption of the microRNA biogenesis machinery in brain and peripheral tissues of individuals with schizophrenia.

Authors:  Romain Rey; Marie-Françoise Suaud-Chagny; Jean-Michel Dorey; Jean-Raymond Teyssier; Thierry d'Amato
Journal:  Transl Psychiatry       Date:  2020-11-04       Impact factor: 6.222

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.